CureVac verlagert Fokus der COVID-19-Impfstoffentwicklung auf mRNA-Technologie der zweiten Generation
mobile.dgap.de/dgap/News/corporate/...neration/?newsID=1480641
CureVac Stock Falls as Company Cancels Vaccine Manufacturing Contracts
www.barrons.com/articles/...c-stock-covid-vaccine-51631627597
mobile.dgap.de/dgap/News/corporate/...neration/?newsID=1480641
CureVac Stock Falls as Company Cancels Vaccine Manufacturing Contracts
www.barrons.com/articles/...c-stock-covid-vaccine-51631627597